30 April 2020

A deal between the University of Oxford and AstraZeneca is announced for global production and distribution of candidate SARS-CoV-2 vaccine. AstraZeneca says it will sell the vaccine at cost during the pandemic- without providing any details on what the cost will be. Sources 1,2

Return to the timeline